1. Gong, Yun, Lv, Yue, Xu, Fanghua, Liu, Zan, Deng, Leihong. 2022. LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma. In Journal of clinical laboratory analysis, 36, e24648. doi:10.1002/jcla.24648. https://pubmed.ncbi.nlm.nih.gov/36082464/
2. Sancak, Yasemin, Bar-Peled, Liron, Zoncu, Roberto, Nada, Shigeyuki, Sabatini, David M. 2010. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. In Cell, 141, 290-303. doi:10.1016/j.cell.2010.02.024. https://pubmed.ncbi.nlm.nih.gov/20381137/
3. De Araujo, Mariana E, Erhart, Gertraud, Buck, Katharina, Huber, Lukas A, Kloss-Brandstätter, Anita. 2013. Polymorphisms in the gene regions of the adaptor complex LAMTOR2/LAMTOR3 and their association with breast cancer risk. In PloS one, 8, e53768. doi:10.1371/journal.pone.0053768. https://pubmed.ncbi.nlm.nih.gov/23341997/
4. Zhang, Xudong, Xue, Cailin, Cui, Xiaohan, Zhu, Chunfu, Qin, Xihu. 2020. Circ_0075829 facilitates the progression of pancreatic carcinoma by sponging miR-1287-5p and activating LAMTOR3 signalling. In Journal of cellular and molecular medicine, 24, 14596-14607. doi:10.1111/jcmm.16089. https://pubmed.ncbi.nlm.nih.gov/33184989/
5. Deng, Lei Hong, Xu, Fang Hua, Zeng, Tao, Xu, Xiang da, Chao, Hai Chao. . [Expression and Clinical Significance of Late Endosomal/Lysosomal Adaptor,Mitogen-activated Protein Kinase and Mammalian Target of Rapamycin Activator 3 in Bladder Carcinoma]. In Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 41, 601-608. doi:10.3881/j.issn.1000-503X.10993. https://pubmed.ncbi.nlm.nih.gov/31699189/
智鼠故事 
